At Biomill, we have a great team with solid technical and commercial knowledge and experience in biosimilars and niche products in Latin American markets.

We have extensive knowledge of each of the countries in terms of their health systems and the ways of accessing medicines in emerging markets. This makes us the ideal representative of pharmaceutical companies that want to make a fast and efficient insertion in Latin America.

In particular, we represent companies in the region that have biological medicines and small molecules complementary to the drugs produced in our Innovative Platforms in their product portfolio.

Our services are:

• We advise companies on how to register their products faster in Latin America, on how to approach each market to obtain greater access to the population and on how to achieve strategic alliances with governments.

• We connect pharmaceutical companies that want to license products with companies that, based on our experience, are the best options as business partners in each Latin American country.

• We actively accompany the go-to-market processes, from scouting, sizing the opportunity, to the best strategies to achieve the best possible market share.

For more information about our services